India has emerged as one of the world's most reliable sources of Active Pharmaceutical Ingredients (APIs) and bulk drugs. With over 3,000 USFDA-approved manufacturing facilities and a cost advantage of 30-50% compared to Western manufacturers, Indian APIs are in demand from regulated markets globally. But sourcing them correctly - with the right specifications, documentation, and regulatory cover - requires a structured approach.
Understanding the Indian API Landscape
India produces APIs across all major therapeutic categories: antibiotics, antivirals, cardiovascular, CNS, oncology, hormones, vitamins, and more. Key manufacturing clusters are located in Hyderabad (Telangana), Ahmedabad and Ankleshwar (Gujarat), Baddi (Himachal Pradesh), Aurangabad (Maharashtra), and New Delhi / NCR. Each cluster has different strengths - for example, Hyderabad is strong in oncology APIs, while Gujarat excels in antibiotics and solvents.
Step 1: Define Your Technical Specification
Before approaching any supplier, you must have a clear technical specification document that includes: CAS number, pharmacopoeial grade (IP, BP, USP, or in-house), purity percentage, particle size (if relevant), polymorphic form, residual solvents limits, and packaging requirements. CAS numbers are especially critical for API sourcing - they uniquely identify the chemical compound and prevent specification errors that could cause regulatory or quality failures.
"One wrong position in a specification can lead to compliance and regulatory problems which no one wants." - Sumsahi Kemicals
Step 2: Identify Qualified Manufacturers
There are several ways to identify CDSCO-approved API manufacturers in India:
- CDSCO website: India's Central Drugs Standard Control Organisation maintains a register of licensed manufacturers.
- WHO-GMP certificates: Indian manufacturers exporting to regulated markets typically hold WHO-GMP or EU-GMP certification.
- USFDA Establishment Inventory: For manufacturers supplying the US market, the FDA's database is publicly searchable.
- Industry directories: Directories like PharmExcil or CII Pharma maintain supplier databases.
- Indenting houses: Working with an established indenting house like Sumsahi Kemicals gives you access to a pre-qualified network built over 20+ years.
Step 3: Request Samples and CoA
Always request a sample with a Certificate of Analysis (CoA) before placing a commercial order. The CoA should include: batch number, manufacture date, retest/expiry date, all test parameters and results, reference to the applicable pharmacopoeia or in-house specification, and QC manager sign-off. Your QA team should test the sample against your internal specification before approval.
Step 4: Evaluate Regulatory Documentation
For Indian pharma companies purchasing for domestic use or for export formulation, you will need: Drug Master File (DMF) or Written Commitment from the API manufacturer; GMP certificate valid at time of purchase; CDSCO license for the API; Pharmacopoeial grade certificate. If you are manufacturing for export to the US or EU, your supplier must hold a US-FDA or EU-GMP certificate respectively.
Step 5: Commercial Terms and Supply Security
Beyond quality, procurement teams must evaluate: lead time, minimum order quantities (MOQs), payment terms, packaging and labelling requirements, and supply chain risk. Single-source dependency on one manufacturer is a known risk - an experienced indenting house maintains multiple qualified sources so that if one manufacturer faces a regulatory action or capacity issue, an alternative can be activated quickly.
Step 6: Logistics and Import Documentation
If you are importing APIs from overseas (China, Europe, etc.) into India, you will need: Bill of Entry, Commercial Invoice, Packing List, Certificate of Origin, CoA from manufacturer, import licence or test licence as applicable under the Drugs and Cosmetics Act. Sumsahi Kemicals manages all import documentation and customs co-ordination, eliminating the complexity for buyers.
New Molecules and Unique APIs
For innovative pharma companies sourcing new molecules or conducting early-stage development, the sourcing process is more complex and may involve custom synthesis, exclusive supply agreements, and IP considerations. Sumsahi Kemicals has a dedicated new molecules and bulk drugs sourcing capability, supporting clients from first sample through to commercial supply.